絞り込み

16385

広告

「ranibizumab」の検索結果

3557件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.

Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform.

Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.

Protective effects on the retina after ranibizumab treatment in an ischemia model.

Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age.

An Analysis of Medicare Reimbursement to Ophthalmologists: Years 2012 to 2013.

Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.

Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial.

Choroidal neovascularization in multifocal choroiditis after dabrafenib and trametinib.

Bilateral choroidal neovascular membrane in a young patient with Sorsby fundus dystrophy: the value of prompt treatment.

Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend Regimen.

IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.

Changes in multiple cytokine concentrations in the aqueous humour of neovascular age-related macular degeneration after 2 months of ranibizumab therapy.

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema.

Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration.

Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study.

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります